GLP-1 Drugs May Slow Aging By Upto Four Years, Early Research Suggest
(RTTNews) - New research from Novo Nordisk A/S (NVO) and Eli Lilly and Company (LLY) suggests that their GLP-1 drugs may slow down certain biological signs of aging by two to four years.